STAT3 and neoplasm: One study demonstrated that the STAT3 inhibitor WP1066 induced immunostimulatory cytokine release to promote T-cell effector function in murine models while also decreasing tumor-mediated immunosuppressive mechanisms of Treg and M2 macrophage accumulation [155].